ES2192031T3 - Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos. - Google Patents

Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.

Info

Publication number
ES2192031T3
ES2192031T3 ES99900500T ES99900500T ES2192031T3 ES 2192031 T3 ES2192031 T3 ES 2192031T3 ES 99900500 T ES99900500 T ES 99900500T ES 99900500 T ES99900500 T ES 99900500T ES 2192031 T3 ES2192031 T3 ES 2192031T3
Authority
ES
Spain
Prior art keywords
amidas
medications
application
radical
preparation procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99900500T
Other languages
English (en)
Inventor
Jean-Luc Haesslein
Michel Klich
Patrick Laurin
Branislav Musicki
Anne-Marie Periers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9800116A external-priority patent/FR2773369B1/fr
Priority claimed from FR9812936A external-priority patent/FR2784681B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2192031T3 publication Critical patent/ES2192031T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/075Benzo[b]pyran-2-ones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención tiene más particularmente por objetivo los compuestos de fórmula (I) en los cuales Y representa un átomo de oxígeno, aquellos en los cuales Y representa un radical NO-alquilo en el cual el radical alquilo comprende hasta 4 átomos de carbono, por ejemplo aquellos en los cuales Y representa el radical NOC2H5. Entre los compuestos preferidos de la invención se pueden citar los compuestos de fórmula (I) en los cuales X representa un radical alquilo que comprende hasta 4 átomos de carbono y principalmente el radical CH3, o también aquellos en los cuales X representa un radical NH2, o también aquellos en los cuales X representa el radical.
ES99900500T 1998-01-08 1999-01-07 Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos. Expired - Lifetime ES2192031T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800116A FR2773369B1 (fr) 1998-01-08 1998-01-08 Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments
FR9812936A FR2784681B1 (fr) 1998-10-15 1998-10-15 Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ES2192031T3 true ES2192031T3 (es) 2003-09-16

Family

ID=26234055

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99900500T Expired - Lifetime ES2192031T3 (es) 1998-01-08 1999-01-07 Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.

Country Status (36)

Country Link
US (2) US6420538B1 (es)
EP (1) EP1045856B1 (es)
JP (1) JP2002500229A (es)
KR (1) KR100604290B1 (es)
CN (2) CN1257164C (es)
AP (1) AP2000001857A0 (es)
AR (1) AR015211A1 (es)
AT (1) ATE236918T1 (es)
AU (1) AU750742B2 (es)
BR (1) BR9906819A (es)
CA (1) CA2317951A1 (es)
CO (1) CO4810298A1 (es)
CZ (1) CZ299840B6 (es)
DE (1) DE69906684T2 (es)
DK (1) DK1045856T3 (es)
DZ (1) DZ2702A1 (es)
EA (1) EA003275B1 (es)
ES (1) ES2192031T3 (es)
HU (1) HUP0100847A3 (es)
ID (1) ID27558A (es)
IL (1) IL137201A0 (es)
MA (1) MA26593A1 (es)
NO (1) NO20003496L (es)
NZ (1) NZ505523A (es)
PA (1) PA8466601A1 (es)
PE (1) PE20000175A1 (es)
PL (1) PL193130B1 (es)
PT (1) PT1045856E (es)
RS (1) RS50047B (es)
SA (1) SA99191247B1 (es)
SI (1) SI1045856T1 (es)
SK (1) SK284734B6 (es)
TN (1) TNSN99003A1 (es)
TR (1) TR200002009T2 (es)
TW (1) TW538046B (es)
WO (1) WO1999035155A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749585B1 (fr) * 1996-06-11 1998-08-14 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
TW538046B (en) * 1998-01-08 2003-06-21 Hoechst Marion Roussel Inc Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof
US6916846B2 (en) 2000-05-12 2005-07-12 Merck & Co. Inc. Coumermycin analogs as chemical dimerizers of chimeric proteins
EP1341769B1 (en) * 2000-12-15 2007-10-17 Vertex Pharmaceuticals Incorporated Bacterial gyrase inhibitors and uses thereof
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
AR042956A1 (es) 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US8193352B2 (en) 2003-01-31 2012-06-05 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8404852B2 (en) 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7569591B2 (en) 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7582641B2 (en) 2003-01-31 2009-09-01 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7618974B2 (en) 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
TW201026695A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Piperidine compounds and uses thereof-596
TW201026694A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
TW201102065A (en) 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
TW201111380A (en) 2009-08-26 2011-04-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
WO2011026107A1 (en) 2009-08-31 2011-03-03 University Of Notre Dame Du Lac Phthalanilate compounds and methods of use
JP2014507413A (ja) 2011-01-14 2014-03-27 バーテックス ファーマシューティカルズ インコーポレイテッド ジャイレース阻害剤である(r)−1−エチル−3−[5−[2−(1−ヒドロキシ−1−メチル−エチル)ピリミジン−5−イル]−7−(テトラヒドロフラン−2−イル)−1h−ベンゾイミダゾール−2−イル]尿素の固体形態
EP2663556B1 (en) 2011-01-14 2014-10-15 Vertex Pharmaceuticals Incorporated Process of making gyrase and topoisomerase iv inhibitors
JP6120775B2 (ja) 2011-01-14 2017-04-26 スペロ トリネム, インコーポレイテッド ジャイレース阻害剤である(r)−1−エチル−3−[6−フルオロ−5−[2−(1−ヒドロキシ−1−メチル−エチル)ピリミジン−5−イル]−7−(テトラヒドロフラン−2−イル)−1h−ベンゾイミダゾール−2−イル]尿素の固体形態
EP2663557B1 (en) 2011-01-14 2015-05-27 Vertex Pharmaceuticals Incorporated Pyrimidine gyrase and topoisomerase iv inhibitors
TWI554515B (zh) 2011-06-20 2016-10-21 維泰克斯製藥公司 旋轉酶(gyrase)及拓樸異構酶抑制劑之磷酸酯
AR093226A1 (es) 2012-07-18 2015-05-27 Vertex Pharma Formas solidas de dihidrogeno fosfato de (r)-2-(5-(2-(3-etilureido)-6-fluoro-7-(tetrahidrofuran-2-il)-1h-benzo[d]imidazol-5-il)pirimidin-2-il)propan-2-ilo y sus sales
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
US20210323957A1 (en) 2018-09-03 2021-10-21 Univerza V Ljubljani New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria
WO2022129327A1 (en) 2020-12-17 2022-06-23 Univerza V Ljubljani New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226978A (en) 1978-03-13 1980-10-07 Miles Laboratories, Inc. β-Galactosyl-umbelliferone-labeled aminoglycoside antibiotics and intermediates in their preparation
EA002271B1 (ru) 1996-03-20 2002-02-28 Хехст Марион Руссель ТРИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ, ОБЛАДАЮЩИЕ АКТИВНОСТЬЮ В ОТНОШЕНИИ ИНТЕГРИНОВ, В ЧАСТНОСТИ В ОТНОШЕНИИ ИНТЕГРИНА АЛЬФАvБЕТА 3, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ, ИСПОЛЬЗУЕМЫЕ В ЭТОМ СПОСОБЕ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МЕДИКАМЕНТОВ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
FR2749585B1 (fr) * 1996-06-11 1998-08-14 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
TW538046B (en) * 1998-01-08 2003-06-21 Hoechst Marion Roussel Inc Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof

Also Published As

Publication number Publication date
CN1291988A (zh) 2001-04-18
WO1999035155A1 (fr) 1999-07-15
NO20003496L (no) 2000-09-08
AU1973699A (en) 1999-07-26
CZ299840B6 (cs) 2008-12-10
DE69906684D1 (de) 2003-05-15
AP2000001857A0 (en) 2000-09-30
US20030060609A1 (en) 2003-03-27
KR100604290B1 (ko) 2006-07-28
SI1045856T1 (en) 2003-08-31
AU750742B2 (en) 2002-07-25
IL137201A0 (en) 2001-07-24
DK1045856T3 (da) 2003-07-21
AR015211A1 (es) 2001-04-18
CN1502617A (zh) 2004-06-09
NO20003496D0 (no) 2000-07-07
ID27558A (id) 2001-04-12
CZ20002523A3 (cs) 2000-11-15
DZ2702A1 (fr) 2003-09-01
TNSN99003A1 (fr) 2005-11-10
TR200002009T2 (tr) 2001-05-21
US6583119B2 (en) 2003-06-24
JP2002500229A (ja) 2002-01-08
EA003275B1 (ru) 2003-04-24
PA8466601A1 (es) 2000-05-24
SK284734B6 (sk) 2005-10-06
PT1045856E (pt) 2003-08-29
RS50047B (sr) 2008-11-28
BR9906819A (pt) 2000-10-17
CN1257164C (zh) 2006-05-24
SK10152000A3 (sk) 2001-07-10
HUP0100847A1 (hu) 2001-07-30
CA2317951A1 (fr) 1999-07-15
EP1045856B1 (fr) 2003-04-09
CN1269833C (zh) 2006-08-16
MA26593A1 (fr) 2004-12-20
YU42700A (sh) 2002-12-10
DE69906684T2 (de) 2003-11-06
KR20010033939A (ko) 2001-04-25
EP1045856A1 (fr) 2000-10-25
PL193130B1 (pl) 2007-01-31
PE20000175A1 (es) 2000-03-09
EA200000749A1 (ru) 2000-12-25
NZ505523A (en) 2003-01-31
ATE236918T1 (de) 2003-04-15
SA99191247B1 (ar) 2006-09-20
CO4810298A1 (es) 1999-06-30
TW538046B (en) 2003-06-21
US6420538B1 (en) 2002-07-16
PL341590A1 (en) 2001-04-23
HUP0100847A3 (en) 2003-07-28

Similar Documents

Publication Publication Date Title
ES2192031T3 (es) Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
CO5040216A1 (es) Agonistas de adenosina a 1, proceso para su preparacion y composiciones farmaceuticas que los contienen
GT199900022A (es) Compuestos para el tratamiento de la isquemia
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
ECSP066405A (es) Compuestos de aril o heteroaril amida
DE50005437D1 (en) Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
AR024138A1 (es) Inhibidores de la proliferacion celular
BG104930A (en) 2-phenyl-1-[2-(-aminoethoxy)-benzyl]-indole in combination with estrogens
DE69920260D1 (de) Antioxidationsmittel
NO20005793L (no) Sammensetninger som inneholder organisk mono- eller dinitrat for behandling av impotens
AR007005A1 (es) Composiciones repelentes de artropodos y procedimiento para repeler artropodos
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos
PA8542601A1 (es) Bifenilcarboxamidas reductoras de lipidos
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
KR960700217A (ko) 액체 페놀성 산화방지제
GT200000049A (es) Compuestos quimicos.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
GR3036142T3 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden